Guidant Jumps

Guidant Corp. jumped $4.80, or 7.8 percent, to $68.25 after striking a deal with Johnson & Johnson (NYSE:JNJ - News) to co-market J&J's drug-coated stent, a new device used to keep arteries clear after surgery.